References
- Albaseri AM, El-Siddig AA, Hussainy AS, et al (2014): Pattern of lymph node pathology in western Saudi Arabia. Asian Pac J Cancer Prev, 15, 4677-81 https://doi.org/10.7314/APJCP.2014.15.11.4677
- Bhattacharya B, Choudhury K, Chattopadhyay B, Mitra D(2013). Primary extranodal non-Hodgkin's lymphoma:A retrospective analysis of its clinicopathological features and treatment outcomes in a tertiary cancer center of eastern India. Clin Cancer Invest J, 2, 218. https://doi.org/10.4103/2278-0513.119269
- Bolukbas F, Kutluturkan S(2014). Symptoms and symptom clusters in non hodgkin's lymphoma patients in Turkey. Asian Pac J Cancer Prev. 15, 7153-8. https://doi.org/10.7314/APJCP.2014.15.17.7153
- Conlan MG, Bast M, Armitage JO, Weisenburger DD(1990). Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol, 8, 1163-72.
- d'Amore F, Christensen BE, Brincker H, et al (1991). Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer Clin Oncol, 27, 1201-8. https://doi.org/10.1016/0277-5379(91)90081-N
- Hashemi-Bahremani M, Parwaresch MR, Tabrizchi H, et al (2007). Lymphomas in Iran. Arch Iranian Medicine, 10, 343-8.
- Hingorjo MR, Syed S (2008). Presentation, staging and diagnosis of lymphoma: a clinical perspective. J Ayub Medical College, 20, 100-3.
- Huff CA , Matsui W, Smith BD, Jones RJ(2006).The paradox of response and survival in cancer therapeutics. Blood, 15, 431-4.
- Jemal A, Bray F, Center MM,et al(2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Johnston PB, Yuan R, Cavalli F, Witzig TE( 2010).Targeted therapy in lymphoma. J Hematol Oncol, 23, 3, 45. https://doi.org/10.1186/1756-8722-3-45
- Moullet I, Salles G, Ketterer N, et al (1998). Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol, 9, 1109-15. https://doi.org/10.1023/A:1008498705032
- Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005). Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematology, 84, 1-12.
- Ng AK, LaCasce A, Travis LB(2011). Long-term complications of lymphoma and its treatment. J Clin Oncol, 29, 1885-92. https://doi.org/10.1200/JCO.2010.32.8427
- Roman E, Smith AG(2011). Epidemiology of lymphomas. Histopathology, 58, 4-14. https://doi.org/10.1111/j.1365-2559.2010.03696.x
- Sader-Ghorra C, Rassy M, Naderi S, et al(2014). Type distribution of lymphomas in Lebanon: five-Year single instituton experience. Asian Pac J Cancer Prev, 15, 5825-8. https://doi.org/10.7314/APJCP.2014.15.14.5825
- Schwenkglenks M, Bendall KL, Pfeil AM,et al(2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & lymphoma, 54, 2426-32. https://doi.org/10.3109/10428194.2013.780287
- Zelenetz AD, Abramson JS, Advani RH, et al (2011). Non-Hodgkin's lymphomas. J Natl Compr Canc Netw, 9, 484-560.
Cited by
- Low-intensity exercise therapy with high frequency improves physical function and mental and physical symptoms in patients with haematological malignancies undergoing chemotherapy pp.09615423, 2018, https://doi.org/10.1111/ecc.12922
- Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy pp.09615423, 2018, https://doi.org/10.1111/ecc.12956